Obésité

, Volume 10, Issue 1, pp 34–40 | Cite as

La sleeve gastrectomie est-elle une procédure bariatrique acceptable ? Résultats à 7 ans révolus

  • J. -M. Catheline
  • R. Dbouk
  • A. Kassem
  • Y. Bendacha
  • C. Bonnel
  • R. Cohen
Article / Article
  • 59 Downloads

Résumé

But de l’étude

Évaluer l’efficacité et la sécurité de la sleeve gastrectomie (SG), 7 années révolues après sa réalisation.

Patients et méthodes

De mai 2004 à novembre 2006, 64 SG ont été consécutivement réalisées par le même opérateur (JMC). Les pourcentages de perte d’excès de poids (%PEP) et de perte d’excès d’IMC (%PEI), ainsi que les comorbidités liées à l’obésité, et les complications liées à la SG, ont été évaluées 2 ans après la SG d’après une étude rétrospective de notre base de données recueillies prospectivement, et 7 ans révolus après la SG d’après un questionnaire soumis aux patients par un des auteurs (RD), d’avril 2012 à novembre 2013.

Résultats

Un recueil complet des données a été obtenu pour 55 patients (85,9 %), incluant 45 patients ayant eu une SG comme seul traitement chirurgical et 10 patients qui ont eu une seconde intervention bariatrique, dans un deuxième temps, du fait d’une insuffisance de perte de poids (7 bypass gastriques, 3 re-SG). Pour ces 55 patients, nous avons constaté une PEP moyenne de 58,4 % à 2 ans et 53,4 % à 7 ans ; une PEI moyenne de 65,1 % à 2 ans et 59,5 % à 7 ans. Trois patients (5,5 %) ont présenté une complication dans les 30 jours postopératoires (2 fistules [3,7 %]), 1 hémorragie (1,9 %). Trois patients (5,5 %) ont présenté une éventration sur site de trocart opérée 10 à 34 mois après la SG.

L’analyse des résultats du groupe des 45 patients ayant eu exclusivement une SG a montré une PEP moyenne de 59,1 % à 2 ans, et 50,4 % à 7 ans ; une PEI moyenne de 66,1 % à 2 ans et 56,5 % à 7 ans. Parmi ces 45 patients, 13 (28,9%) avaient un traitement antidiabétique avant la SG, et 6 (15,6 %) 7 ans après la SG (diminution de 53,9 %) ; 17 (37,8 %) avaient un traitement antihypertenseur avant la SG et 9 (20 %) 7 ans après (diminution de 47,1 %) ; 12 (26,7 %) avaient un traitement hypolipémiant avant la SG, et 6 (15,5 %) 7 ans après (diminution de 50 %) ; 25 (55,6 %) avaient un syndrome d’apnée du sommeil (SAS) avant la SG et 8 (17,8 %) 7 ans après (diminution de 68 %). Par ailleurs, 5 patients (11,1 %) avaient un reflux gastrooesophagien (RGO) traité par IPP avant la SG, et 15 (33,3 %) 7 ans après (augmentation de 200 %).

Conclusion

7 années révolues après une SG, la perte de poids était satisfaisante d’après les critères de Reinhold, peu de complications ont été constatées, la diminution des comorbidités a été importante, mais la fréquence du RGO augmentée.

Mots clés

Sleeve gastrectomie Obésité Re-sleeve gastrectomie Bypass gastrique 

Is the sleeve gastrectomy an acceptable bariatric procedure? Results with 7 years completed

Abstract

Aims

Our primary objective was to evaluate the efficacy and safety of sleeve gastrectomy [SG] at 7 years post SG.

Methods

From May 2004 to November 2006, 64 SG were consecutively performed by the same operator (JMC). The percentage of excess weight loss (%EWL), the percentage of excess BMI loss [%EBL], as well as the presence of comorbidities, and surgical complications, were evaluated at 2 years according a retrospective study of our database collected prospectively, and at 7 years according to a patient survey conducted from April 2012 to December 2013.

Results

A complete record was obtained for 55 patients (85.9%), including 45 patients who only have had a SG, and 10 who have had a second bariatric procedure due to insufficient weight loss (7 gastric bypasses, 3 re-SG). The mean %EWL of 55 patients was 58.4% at 2 years and 53.4% at 7 years; the mean %EBL was 65.1% at 2 years and 59.5% at 7 years. Three patients [5.5%] have had postoperative complications (2 fistulas [3.7%]), 1 hemorrhage (1.9%). Three cases (5.5%) of trocar site hernia were observed between 10 months and 37 months post SG.

The group analysis of 45 patients who have had only a SG found a mean of 59.1% of %EWL at 2 years and 50.4% at 7 years; the mean %EBL was 66.1% at 2 years and 56.5% at 7 years. For these 45 patients we found a favorable evolution of comorbidities: 13 patients (28.9%) had preoperative antidiabetic treatment and 6 (15.6%) at 7 years post SG (decrease of 53.9%); 17 (37.8%) were treated preoperatively for hypertension and 9 (20%) at 7 years (decrease of 47.1%); 12 (26.7%) had preoperative lipid-lowering therapy and 6 (15.5%) at 7 years (decrease of 50%); 25 (55.6%) had a preoperative sleep apnea syndrom (SAS) and 8 (17.8%) at 7 years (decrease of 68%). Medical treatment for gastrooesophageal reflux disease (GERD) was observed in 5 patients (11.1%) preoperatively and in 15 patients (33.3%) at 7 years post SG (increase of 200%).

Conclusion

At 7 years post SG, weight loss was satisfying in agreement with Reinhold. Comorbidities decreased but the frequency of GERD was increased.

Keywords

Sleeve gastrectomy Obesity Re-sleeve gastrectomy Gastric bypass 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Arias E, Martinez PR, Ka Ming Li V, et al (2009) Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity. Obes Surg 19:544–548CrossRefPubMedGoogle Scholar
  2. 2.
    Menenakos E, Stamou KM, Albanopoulos K, et al (2010) Laparoscopic sleeve gastrectomy performed with intent to treat morbid obesity: a prospective single-center study of 261 patients with a median follow-up of 1 year. Obes Surg 20:276–282CrossRefPubMedGoogle Scholar
  3. 3.
    Gumbs AA, Gagner M, Dakin G, Pomp A. (2007) Sleeve gastrectomy for morbid obesity. Obes Surg 17:962–969CrossRefPubMedGoogle Scholar
  4. 4.
    Fuks D, Verhaeghe P, Behant O, et al (2009) Results of laparoscopic sleeve gastrectomy: A prospective study in 135 patients with morbid obesity. Surgery 145:106–113CrossRefPubMedGoogle Scholar
  5. 5.
    Himpens J, Dobbeleir J, Peeters G. (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319–324CrossRefPubMedGoogle Scholar
  6. 6.
  7. 7.
  8. 8.
    Catheline JM, Cohen R, Khochtali I, et al (2006) Treatment of super super morbid obesity by sleeve gastrectomy. Presse Med 35:383–387CrossRefPubMedGoogle Scholar
  9. 9.
    Reinhold RB. (1982) Critical analysis of long term weight loss following gastric bypass. Surg Gynecol Obstet 155:385–394PubMedGoogle Scholar
  10. 10.
    Mechanick JI, Youdim A, Jones DB, et al (2013) Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity; 21[suppl]: S1–S27. doi:10.1002/oby.20461CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Adams TD, Gress RE, Smith SC, et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761CrossRefPubMedGoogle Scholar
  12. 12.
    Braghetto I, Csendes A, Lanzarini E, et al (2012) Is laparoscopic sleeve gastrectomy an acceptable primary bariatric procedure in obese patients? Early and 5-year postoperative results. Surg Laparosc Endosc Percutan Tech 22:479–486CrossRefPubMedGoogle Scholar
  13. 13.
    Franco JV, Ruiz PA, Palermo M, et al (2011) Review of studies comparing three laparoscopic procédures in bariatric sugery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding; Obes Surg 21:1458–1468CrossRefPubMedGoogle Scholar
  14. 14.
    Hauser DL, Titchner RL, Wilson MA, et al (2010) Long term outcome of laparoscopic Roux-en-Y gastric bypass in US veterans. Obes Surg 20:283–289CrossRefPubMedGoogle Scholar
  15. 15.
    Langer F, Bohdjalian A, Shakeri-Leidenmuhler S. (2010) Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass. Indications and outcome. Obes Surg 20:835–840CrossRefGoogle Scholar
  16. 16.
    Gagner M, Deitel M, Kalberer TL, et al (2009) The second international consensus summit for sleeve gastrectomy. Surg Obes Relat Dis 5:476–485CrossRefPubMedGoogle Scholar
  17. 17.
    Deitel M, Gagner M, Erickson AL, et al (2011) Third international summit: curent status of sleeve gastrectomy. Surg Obes Relat Dis 7:449–459Google Scholar
  18. 18.
    Iannelli A, Schneck AS, Noel P, et al (2011) Re-sleeve gastrectomy for failed laparoscopic sleeve gastrectomy: a feasability sutdy. Obes Surg 21:832–835CrossRefPubMedGoogle Scholar
  19. 19.
    Catheline JM, Fysekidis M, Bihan H, et al (2011) Better results in weight loss after the Second gastrectomy in re-sleeve gastrectomy. J Obes Weig Loss Ther 1:107. doi: 10.4172/2165-7904.1000107Google Scholar
  20. 20.
    Cohen R, Uzzan B, Bihan H, et al (2005) Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes Surg 15:1501–1502CrossRefPubMedGoogle Scholar
  21. 21.
    Basso N, Casella G, Rizzello M, et al (2011) Laparoscopic sleeve gastrectomy as a first stage or définitive intent in 300 consecutive cases. Surg Endosc 25 444–449CrossRefPubMedGoogle Scholar
  22. 22.
    Nocca D, Krawczykowsky D, Bomans B, et al (2008) A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years. Obes Surg 18:560–565CrossRefPubMedGoogle Scholar
  23. 23.
    Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al (2010) Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 20:535–540CrossRefPubMedGoogle Scholar
  24. 24.
    Catheline JM, Fysekidis M, Dbouk R, et al (2012) Weight loss after sleeve gastrectomy in super superobesity. J Obes 959260.doi: 10.1155/2012/959260Google Scholar
  25. 25.
    Consten EC, Gagner M, Pomp A, Inabnet WB. (2004) Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane. Obes Surg 14:1360–1366CrossRefPubMedGoogle Scholar
  26. 26.
    D’Hondt M, Vanneste S, Pottel H, et al (2011) Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc 25:2498–2504CrossRefPubMedGoogle Scholar
  27. 27.
    Rawlins L, Rawlins MP, Brown CC, Schumacher DL (2013) Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis 9:21–25CrossRefPubMedGoogle Scholar
  28. 28.
    Chazelet C, Verhaeghe P, Perterli R, et al (2009) La gastrectomie longitudinale [sleeve gastrectomy] comme unique chirurgie bariatrique: résultats d’une étude rétrospective multicentrique de 446 patients. J Chir 146:368–372CrossRefGoogle Scholar
  29. 29.
    Csendes A, Braghetto I, Leon P, et al (2010) Management of leaks after laparoscopic sleeve gastrectomy in patients with obesity. J Gastrointest Surg 14:1343–1348CrossRefPubMedGoogle Scholar
  30. 30.
    Gagner M. (2010) Leaks after sleeve gastrectomy are associated with smaller bougies: prevention and treatment strategies. Surg Laparosc Endosc Percutan Tech 20:166–169CrossRefPubMedGoogle Scholar
  31. 31.
    Saif, T, Strain GW, Dakin G, et al (2012) Evaluation of nutrient status after laparoscopic sleeve gastrectomy 1, 3, and 5 years after surgery. Surg Obes Relat Dis 8:542–547CrossRefPubMedGoogle Scholar
  32. 32.
    Santoro S. (2007) Technical aspects in sleeve gastrectomy. Obes Surg 17:1534–1535CrossRefPubMedGoogle Scholar
  33. 33.
    Strain GW, Saif T, Gagner M, et al (2011) Cross-sectional review of effects of laparoscopic sleeve gastrectomy at 1, 3, and 5 years. Surg Obes Relat Dis 7:714–719CrossRefPubMedGoogle Scholar
  34. 34.
    Lazoura O, Zacharoulis D, Triantafyllidis G, et al (2011) Symptoms of gastroesophageal reflux following laparoscopic sleeve gastrectomy are related to the final shape of the sleeve as depicted by radiology. Obes Surg 21:295–299CrossRefPubMedGoogle Scholar
  35. 35.
    Catheline JM, Fysekidis M, Bachner I, et al (2013) Five-year results of sleeve gastrectomy. J Visc Surg http://dx.doi.org/10.1016/j.jviscsurg.2013.08.008 Google Scholar

Copyright information

© Springer-Verlag France 2014

Authors and Affiliations

  • J. -M. Catheline
    • 1
  • R. Dbouk
    • 1
  • A. Kassem
    • 1
  • Y. Bendacha
    • 1
  • C. Bonnel
    • 1
  • R. Cohen
    • 2
  1. 1.Service de chirurgie viscéraleCentre Hospitalier de Saint-DenisSaint-DenisFrance
  2. 2.Service d’endocrinologieCentre Hospitalier de Saint-DenisSaint-DenisFrance

Personalised recommendations